24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The role of pre-existing immunity for influenza vaccine responses is of great importance for public health, and thus has been studied in various contexts, yet the impact of differential priming on vaccine responses in the midst of antigenic drift remains to be elucidated. To address this with antigenically related viruses, mice were first primed by either infection or immunization with A/Puerto Rico/8/34 (PR8) virus, then immunized with whole-inactivated A/Fort Monmouth/1/47 (FM1) virus. The ensuing vaccine responses and the protective efficacy of FM1 were superior in PR8 infection-primed mice compared to PR8 immunization-primed or unprimed mice. Increased FM1-specific Ab responses of PR8 infection-primed mice also broadened cross-reactivity against contemporary as well as antigenically more drifted strains. Further, prior infection heightened the protective efficacy of antigenically distant strains, such as A/Brisbane/59/2006 infection followed by immunization with split pandemic H1N1 vaccine (A/California/07/2009). Therefore, influenza infection is a significant priming event that intensifies future vaccine responses against drift strains.

          Related collections

          Author and article information

          Journal
          8406899
          7945
          Vaccine
          Vaccine
          Vaccine
          0264-410X
          1873-2518
          26 December 2015
          17 December 2015
          20 January 2016
          20 January 2017
          : 34
          : 4
          : 495-502
          Affiliations
          [1 ]Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
          [2 ]Department of Microbiology and Immunology, School of Medicine, Emory University, 1518 Clifton Rd, Atlanta, GA 30322, USA
          [3 ]Department of Microbiology and Immunology, Emory Vaccine Center, Emory University, 954 Gatewood Rd, Atlanta, GA, 30329, USA
          Author notes
          [2]

          Current address: Department of Microbiology and Immunology, School of Medicine, Emory University, 1518 Clifton Rd, Atlanta, GA 30322, USA

          [4 ]Address correspondence and reprint requests to Dr. Suryaprakash Sambhara, 1600 Clifton Road, NE, Centers for Disease Control and Prevention, Atlanta, GA 30333, 404-639-3800; (Fax) 404-639-2350; zao1@ 123456cdc.gov or Dr. Joshy Jacob, 954 Gatewood Road, Emory Vaccine Center, Emory University, Atlanta, GA, 30329. 404-727-7919; (Fax) 404-727-8199; joshy.jacob@ 123456emory.edu
          Article
          PMC4713344 PMC4713344 4713344 nihpa745183
          10.1016/j.vaccine.2015.11.077
          4713344
          26706277
          4a94609c-19f9-41d8-b4ac-73f52ee3f68c
          History
          Categories
          Article

          influenza virus,infection,antigenic drift,vaccine efficacy,pandemic H1N1

          Comments

          Comment on this article